» Articles » PMID: 12941575

The Environment and Parkinson's Disease: is the Nigrostriatal System Preferentially Targeted by Neurotoxins?

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2003 Aug 28
PMID 12941575
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Recent epidemiological and experimental studies have renewed interest in the hypothesis that the environment has a role in the pathogenesis of Parkinson's disease (PD). Epidemiological studies have identified protective associations (eg, smoking) as well as adverse risk factors (eg, pesticide exposure) for PD. The concordance rate of PD in pairs of dizygotic twins is similar to that in pairs of monozygotic twins, supporting a role of non-genetic risk factors. New models of selective nigrostriatal damage--such as neurotoxicity induced by rotenone or paraquat--have emphasised that environmental agents may contribute to the neurodegenerative process in PD. Toxins interact, in vitro and in vivo, with alpha-synuclein, an endogenous protein that is implicated in pathology of PD. Similarities between clinical and experimental findings, such as the role of pesticide exposure as a potential environmental risk factor, highlight the importance of a multidisciplinary approach to the aetiology of PD.

Citing Articles

The Protective Effect of Docosahexaenoic Acid on Mitochondria in SH-SY5Y Model of Rotenone-Induced Toxicity.

Eggers B, Stepien J, Reker A, Esser S, Pfeiffer K, Pawlas M Metabolites. 2025; 15(1.

PMID: 39852372 PMC: 11767228. DOI: 10.3390/metabo15010029.


The role of the gut microbiota and the nicotinate/nicotinamide pathway in rotenone-induced neurotoxicity.

Sai Y, Ge W, Zhong L, Zhang Q, Xiao J, Shan Y Curr Res Toxicol. 2025; 8():100212.

PMID: 39834518 PMC: 11743872. DOI: 10.1016/j.crtox.2024.100212.


Modeling of Parkinson's Disease in Different Models.

Subhan I, Siddique Y CNS Neurol Disord Drug Targets. 2024; 24(2):102-114.

PMID: 39354776 DOI: 10.2174/0118715273326866240922193029.


The PM20D1-NADA pathway protects against Parkinson's disease.

Yang Y, Chen S, Zhang L, Zhang G, Liu Y, Li Y Cell Death Differ. 2024; 31(11):1545-1560.

PMID: 39174646 PMC: 11519464. DOI: 10.1038/s41418-024-01356-9.


Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer.

Zhang H, Zhou Y, Feng Y, Hou W, Chen Y, Xing Z Clin Transl Med. 2024; 14(5):e1678.

PMID: 38736108 PMC: 11089090. DOI: 10.1002/ctm2.1678.